Sumatriptan Succinate Tablet, Film Coated
Product Images NDC 51407-011

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 51407-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407 011 09l

Sumatriptan Tablets, USP 25 mg by Golden State Medical Supply, Inc. The film-coated oral tablet package contains 9 tablets. The label includes NDC 51407-011-09 and directs users to see the package insert for dosage information. Storage instructions specify 20° to 25°C (68° to 77°F). The label is marked Rx only.*

FDA Label Image

51407 012 09lb

Label for Sumatriptan tablets, USP 50 mg by Golden State Medical Supply, Inc. The film-coated tablet package contains 9 tablets. The label includes the NDC 51407-012-09, dosing instructions advice, storage conditions, and controlled substance reminder. The product is prescription only (Rx only).*

FDA Label Image

51407 013 09lb

Label for Sumatriptan Tablets USP 100 mg, oral film-coated tablets packaged in a container of 9 tablets. The label displays the NDC 51407-013-09 and indicates the product is by Golden State Medical Supply, Inc. Important storage instructions and dispensing information, including 'Rx only,' are printed on the label.*

FDA Label Image

Image 01

Chemical structure of sumatriptan succinate, depicting the molecular arrangement of atoms including an indole ring, sulfonamide group, and succinate moiety.*

FDA Label Image

Image 02

A line graph showing the Estimated Probability of Response over Time in Minutes from Initial Dose for placebo and sumatriptan succinate tablets at 25 mg, 50 mg, and 100 mg doses. The graph illustrates increasing response probabilities over 240 minutes, with higher doses generally showing greater response.*

FDA Label Image

Image 03

A line graph showing the estimated probability of remediation or rescue over time in hours from the initial dose for Sumatriptan Succinate tablets at 25 mg, 50 mg, and 100 mg strengths compared to placebo. The graph depicts increasing probabilities over a 24-hour period, with placebo having the highest probability, followed by 25 mg, 50 mg, and 100 mg doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.